DEFITELIO: payments to doctors
Payments that named DEFITELIO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3M
- Providers
- 1,552
- Transactions
- 4,534
- Average per transaction
- $672
The per-transaction average — $672 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,552 providers the average total is $1,965, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| JAZZ Pharmaceuticals Inc. | $2,720,340 | 89.2% |
| Jazz Pharmaceuticals Inc. | $328,766 | 10.8% |